Home › Calculator › PTCT Dividend Calculator 2026
PTCT Dividend DRIP Calculator 2026
2.46% YieldHealthcarePTC Therapeutics, Inc. · NASDAQ
Price: $81.35 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PTCT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PTCT snowball 📈
$10,000 in PTCT → $10.49M in 10 years · $20.99/month
About PTC Therapeutics, Inc. (PTCT) — Dividend Analysis 2026
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older. Leveraging its proprietary splicing platform, the company is also actively developing PTC518, a promising therapeutic candidate aimed at treating Huntington's disease. To bolster its research and development capabilities, PTC Therapeutics has established strategic collaborations, including partnerships with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation, focusing on advancing drug discovery and development research, particularly in regenerative medicine. Additionally, it collaborates with Akcea Therapeutics, Inc. for the commercialization of Tegsedi and Waylivra in the Latin America and Caribbean region. Established in 1998, PTC Therapeutics, Inc. maintains its corporate headquarters in South Plainfield, New Jersey.
Compare PTCT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PTCT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PTCT position with:
🌍 PTCT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PTCT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.46% | -0.34% | $246 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.09% | -0.71% | $209 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.97% | -0.83% | $197 / yr |
| 🇬🇧 UK ISA | 0% | 2.46% | -0.34% | $246 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.24% | -0.56% | $224 / yr |
| 🇨🇦 TFSA | 0% | 2.46% | -0.34% | $246 / yr |
| 🇨🇦 CA Taxable | 25% | 1.84% | -0.95% | $185 / yr |
| 🇦🇺 Super (pension) | 15% | 2.09% | -0.71% | $209 / yr |
| 🇦🇺 AU Taxable | 30% | 1.72% | -1.08% | $172 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.81% | -0.99% | $181 / yr |
| 🇫🇷 FR Taxable | 30% | 1.72% | -1.08% | $172 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PTCT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PTCT Dividend Payment Schedule
PTCT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 PTCT vs Healthcare Benchmarks
How PTCT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PTCT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PTCT Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where PTCT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PTCT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
PTC Therapeutics, Inc. (PTCT) is currently trading at $81.35, trading near its 52-week high. The current dividend yield is 2.46% based on an annual payout of $2.00 per share.
PTCT (PTC Therapeutics, Inc.) — 2.46% Dividend Yield Analysis
PTC Therapeutics, Inc. (PTCT) is a healthcare stock currently trading at $81.35 with a dividend yield of 2.46%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest PTCT News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.